{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:54:19Z","timestamp":1792205659391,"version":"4.4.0"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2025,9,10]]},"DOI":"10.1253\/circrep.cr-25-0101","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T18:06:58Z","timestamp":1751911618000},"page":"764-773","source":"Crossref","is-referenced-by-count":5,"title":["Feasibility and Safety of Atrial Biopsy\u3000\u2015 Evidence From 1,000 Cases \u2015"],"prefix":"10.1253","volume":"7","author":[{"given":"Toyokazu","family":"Otsubo","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"},{"name":"Division of Cardiology, Saga-ken Medical Centre Koseikan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodai","family":"Shinzato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Tsuruta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Edayoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Shichida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Osako","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saga-ken Medical Centre Koseikan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kawano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Futsukaichi Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Yokoi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fukui","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Hirota","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masateru","family":"Takigawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Shintani-Domoto","sequence":"additional","affiliation":[{"name":"Department of Integrated Diagnostic Pathology, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Ito","sequence":"additional","affiliation":[{"name":"Laboratory for Cardiovascular Genomics and Informatics, RIKEN Center for Integrative Medical Sciences"},{"name":"Department of Advanced Biomedical Data Science, Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Aoki","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Pathology and Microbiology, Faculty of Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Education and Research Center for Community Medicine, Faculty of Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo"},{"name":"Department of Frontier Cardiovascular Science, The University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Node","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Saga University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera JA, Chugh SS, et al. Atrial cardiomyopathy revisited-evolution of a concept: A clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). <i>Europace<\/i> 2024; 26: euae204.","DOI":"10.1093\/europace\/euae204"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamaguchi T. Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective. <i>J Cardiol<\/i> 2025; 85: 47\u201355.","DOI":"10.1016\/j.jjcc.2024.05.007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Masuda M, Matsuda Y, Uematsu H, Sugino A, Ooka H, Kudo S, et al. Prognostic impact of atrial cardiomyopathy: Long-term follow-up of patients with and without low-voltage areas following atrial fibrillation ablation. <i>Heart Rhythm<\/i> 2024; 21: 378\u2013386.","DOI":"10.1016\/j.hrthm.2023.12.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kim J, Park SJ, Jeong DS, Chung S, Jeon K, Bak M, et al. Left atrial strain predicts fibrosis of left atrial appendage in patients with atrial fibrillation undergoing totally thoracoscopic ablation. <i>Front Cardiovasc Med<\/i> 2023; 10: 1130372.","DOI":"10.3389\/fcvm.2023.1130372"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study. <i>JAMA<\/i> 2014; 311: 498\u2013506.","DOI":"10.1001\/jama.2014.3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yamaguchi T, Otsubo T, Takahashi Y, Nakashima K, Fukui A, Hirota K, et al. Atrial structural remodeling in patients with atrial fibrillation is a diffuse fibrotic process: Evidence from high-density voltage mapping and atrial biopsy. <i>J Am Heart Assoc<\/i> 2022; 11: e024521.","DOI":"10.1161\/JAHA.121.024521"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Knappe D, Vogler J, Weimann J, Banas V, Obergassel J, Yildirim S, et al. Left atrial reservoir strain and recurrence of atrial fibrillation following de-novo pulmonary vein isolation: Results of the ASTRA-AF pilot study. <i>Circ J<\/i> 2025; 89: 153\u2013161.","DOI":"10.1253\/circj.CJ-24-0209"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Otsuka K, Kawano H, Koike H, Sueyoshi E, Arakawa S, Fukae S, et al. Atrial lesion and diastolic dysfunction may be associated with atrial fibrillation in patients with cardiac amyloidosis. <i>Circ Rep<\/i> 2024; 6: 539\u2013546.","DOI":"10.1253\/circrep.CR-24-0116"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Marzak H, Hammann J, Matsushita K, Ringele R, Fitouchi S, Severac F, et al. Left atrial low-voltage zone assessment and voltage-guided ablation outcome in patients with atrial fibrillation-induced tachycardiomyopathy. <i>Circ J<\/i> 2025; 89: 204\u2013213.","DOI":"10.1253\/circj.CJ-24-0079"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Shinzato K, Osako R, et al. Histological validation of atrial structural remodeling in patients with atrial fibrillation. <i>Eur Heart J<\/i> 2023; 44: 3339\u20133353.","DOI":"10.1093\/eurheartj\/ehad396"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Shinzato K, Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Yoshioka G, et al. Atrial amyloidosis identified by biopsy in atrial fibrillation: Prevalence and clinical presentation. <i>Eur Heart J<\/i> 2025, doi:10.1093\/eurheartj\/ehaf332.","DOI":"10.1093\/eurheartj\/ehaf332"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. <i>Circulation<\/i> 1997; 96: 1180\u20131184.","DOI":"10.1161\/01.CIR.96.4.1180"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sepehri Shamloo A, Husser D, Buettner P, Klingel K, Hindricks G, Bollmann A. Atrial septum biopsy for direct substrate characterization in atrial fibrillation. <i>J Cardiovasc Electrophysiol<\/i> 2020; 31: 308\u2013312.","DOI":"10.1111\/jce.14308"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Martens P, Cooper LT, Tang WHW. Diagnostic approach for suspected acute myocarditis: Considerations for standardization and broadening clinical spectrum. <i>J Am Heart Assoc<\/i> 2023; 12: e031454.","DOI":"10.1161\/JAHA.123.031454"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, et al. A statement on the appropriate administration of tafamidis in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2019; 84: 15\u201317.","DOI":"10.1253\/circj.CJ-19-0811"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al.; ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Elliott P, Gundapaneni B, Sultan MB, Ines M, Garcia-Pavia P. Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms. <i>Eur J Heart Fail<\/i> 2023; 25: 2060\u20132064.","DOI":"10.1002\/ejhf.2974"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kumar S, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Colby C, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. <i>J Clin Oncol<\/i> 2012; 30: 989\u2013995.","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Minamisawa M, Konishi H, Kitano Y, Abe H, Togo K, Izumiya Y. Patient journey to transthyretin cardiac amyloidosis diagnosis: A Japanese claims database study. <i>Circ J<\/i> 2025; 89: 432\u2013441.","DOI":"10.1253\/circj.CJ-24-0666"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Takashio S, Kato T, Tashima H, Irie H, Komohara Y, Oguni T, et al. Prevalence of cardiac amyloidosis in patients undergoing carpal tunnel release with amyloid deposition. <i>Circ J<\/i> 2023; 87: 1047\u20131055.","DOI":"10.1253\/circj.CJ-23-0223"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Prasad P, Howell S, Sanghai S, Stecker E, Henrikson CA, Masri A, et al. Targeted screening for transthyretin amyloid cardiomyopathy in patients with atrial fibrillation. <i>Circulation<\/i> 2022; 146: 1730\u20131732.","DOI":"10.1161\/CIRCULATIONAHA.122.060596"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yamasaki H, Kondo H, Shiroo T, Iwata N, Masuda T, Makita T, et al. Efficacy of computed tomography-based evaluation of myocardial extracellular volume combined with red flags for early screening of concealed cardiac amyloidosis in patients with atrial fibrillation. <i>Circ J<\/i> 2024; 88: 1167\u20131175.","DOI":"10.1253\/circj.CJ-23-0948"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. R\u00f6cken C, Peters B, Juenemann G, Saeger W, Klein HU, Huth C, et al. Atrial amyloidosis: An arrhythmogenic substrate for persistent atrial fibrillation. <i>Circulation<\/i> 2002; 106: 2091\u20132097.","DOI":"10.1161\/01.CIR.0000034511.06350.DF"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Holzmann M, Nicko A, K\u00fchl U, Noutsias M, Poller W, Hoffmann W, et al. Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. <i>Circulation<\/i> 2008; 118: 1722\u20131728.","DOI":"10.1161\/CIRCULATIONAHA.107.743427"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. S\u0142awek S, Araszkiewicz A, Gaczkowska A, Koszarska J, Celi\u0144ski D, Grygier M, et al. Endomyocardial biopsy via the femoral access-still safe and valuable diagnostic tool. <i>BMC Cardiovasc Disord<\/i> 2016; 16: 1\u20138.","DOI":"10.1186\/s12872-016-0406-0"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/9\/7_CR-25-0101\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T03:50:05Z","timestamp":1757735405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/7\/9\/7_CR-25-0101\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-25-0101","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"article-number":"CR-25-0101"}}